Screening and Treatment of Perinatal Depression and Anxiety

Edited by
December 2022
208 pages
  • ISBN978-3-0365-5823-3 (Hardback)
  • ISBN978-3-0365-5824-0 (PDF)

This book is a reprint of the Special Issue Screening and Treatment of Perinatal Depression and Anxiety that was published in

Environmental & Earth Sciences
Medicine & Pharmacology
Public Health & Healthcare

This reprint focuses on the assessment, screening and intervention of perinatal depression and anxiety, which have been internationally recognized as relevant mental health problems affecting the whole family system. The contents are of interest for all professionals working in the field of perinatal mental health. Special attention in the reprint is given to three main domains: clinical characteristics of perinatal depression and anxiety in women and men; psychometric properties and usefulness of screening tools; and types of intervention.

The first area focuses on the investigation of prevalence, risk factors and predictors of perinatal depression and anxiety, considering different samples of women and/or men, during the prenatal and postpartum period; a glance is also given to perinatal mental health difficulties experienced during the COVID-19 pandemic. The second area is focused on the description of psychometric properties of tools for the detection and screening of perinatal anxiety and depression. This section includes contributions regarding: comparisons among different tools, further validation of already existing questionnaires and validation of new instruments, which could enhance the early detection of depressive and anxiety symptoms. The third area focuses on different approaches of intervention to reduce perinatal depression and anxiety, including gender-transformative interventions to address perinatal mental health and clinical guidelines for the pharmacological management of both depression and anxiety.

  • Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Edinburgh Postnatal Depression Scale (EPDS); Slovakia; validity; postpartum depression; pregnancy; COVID-19; pandemic stress; correlates of stress; infection; preparedness; Insomnia Symptom Questionnaire; sleep disorders; perinatal period; internal consistency; convergent validity; postpartum depression; predictors; longitudinal study; anxiety; childbirth experience; clinical practice guideline; depression; anxiety; antidepressant; psychotropic medications; peripartum; childbirth; fear; assessment; birth; questionnaire development; caesarean; vaginal; childbirth anxiety; anxiety in pregnancy; COVID-19; SARS-CoV-2; pandemic; support; perinatal care; pregnancy; childbirth school; perinatal; screening; validation; EPDS; perinatal mental health; anxiety disorders; perinatal anxiety; fear of childbirth; screening; postnatal; anxiety; identifying; screening; GAD; EPDS; questionnaires; screening; structural validity; perinatal depression; perinatal anxiety; pregnancy; responsiveness; postpartum depression; online and offline intervention; postpartum women; e-health technology; social stigma; social support; study protocol; perinatal depression; fathers; preterm birth; severity of prematurity; ELBW; VLBW; parenting stress; partner’s influence; perinatal mental health; gender transformative interventions; scoping review; LMIC